Ahit suppresses cardiac hypertrophy through binding with SUZ12 to regulate PRC2 occupancy on the MEF2A (myocyte enhancer factor 2A) promoter (Figure 2) (37). Here, MEF2A is linked to cardiac hypertrophy.